Partnerships Partnering News

09.05.2018

4D Molecular Therapeutics Raises $90 Million Series B Financing

08.16.2018

BioNTech Signs Collaboration Agreement with Pfizer to Develop mRNA-based Vaccines for Prevention of Influenza

08.08.2018

SANGAMO ANNOUNCES POSITIVE PRELIMINARY DATA FROM THE PHASE 1/2 ALTA STUDY EVALUATING SB-525 GENE THERAPY FOR HEMOPHILIA A

07.03.2018

RESOLUTE:13 academic & industry partners join forces to unlock SLCs for new therapies

05.31.2018

Cortexyme Completes $76 Million Series B Financing and Provides Update on Clinical Development Progress

05.08.2018

XtalPi Inc. Announces Strategic Research Collaboration with Pfizer Inc. to Develop Artificial Intelligence-Powered Molecular Modeling Technology for Drug Discovery

05.08.2018

New project to enhance nanomedicine development

05.07.2018

Wave Life Sciences Highlights Progress on Hepatic Collaboration with Pfizer

05.01.2018

HUB Announces Collaboration with Pfizer Inc. on Human Gut Organoids for IBD

03.19.2018

BioDuro Collaboration with Pfizer Inc. Leads to Creation of a Shelf-Stable Fluorosulfation Reagent

03.12.2018

BIOGEN TO ACQUIRE FROM PFIZER FIRST-IN-CLASS PHASE 2b READY ASSET FOR COGNITIVE IMPAIRMENT ASSOCIATED WITH SCHIZOPHRENIA

03.09.2018

AM‐Pharma announces Phase II study results of recAP in sepsis‐associated Acute Kidney Injury